Genflow Biosciences plc (LON:GENF – Get Free Report)’s share price traded up 2.7% on Wednesday . The stock traded as high as GBX 2.14 and last traded at GBX 1.90. 6,361,326 shares were traded during mid-day trading, an increase of 92% from the average session volume of 3,310,278 shares. The stock had previously closed at GBX 1.85.
Genflow Biosciences Trading Up 10.5%
The stock has a market cap of £10.36 million, a PE ratio of -4.18 and a beta of 2.37. The business has a 50 day moving average of GBX 1.90 and a 200-day moving average of GBX 1.64.
About Genflow Biosciences
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Further Reading
- Five stocks we like better than Genflow Biosciences
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- This makes me furious
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
